A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study

H. Ch'ang,T. Hwang,H. Wang,M Chang,Y. Tien,J. Chen,R. Hsieh,P Lin,Y Shan,A. Cheng,L. Chen

A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study

2009

H. Ch'ang
T. Hwang
H. Wang
M Chang
Y. Tien
J. Chen
R. Hsieh
P Lin
Y Shan
A. Cheng
L. Chen

e15562 The optimal management of LAPC remains controversial. The efficacy of CCRT is hampered by early systemic dissemination. To treat undetectable metastases and to select patients who are likely...

Keywords:

Pancreatic cancer
General surgery
Chemoradiotherapy
Gemcitabine
Induction chemotherapy
Oncology
Medicine
Internal medicine
Phases of clinical research
locally advanced pancreatic cancer
optimal management

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations